Shopping Cart
- Remove All
- Your shopping cart is currently empty
RF9 is an effective and selective antagonist of the Neuropeptide FF receptor (Kis: 58±5 and 75±9 nM for hNPFF1R and hNPFF2R, respectively).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $233 | 35 days | |
5 mg | $858 | 35 days | |
10 mg | $1,480 | 35 days |
Description | RF9 is an effective and selective antagonist of the Neuropeptide FF receptor (Kis: 58±5 and 75±9 nM for hNPFF1R and hNPFF2R, respectively). |
Targets&IC50 | NPFF2R (human):75±9 nM(ki), NPFF1R (human):(ki)58±5 nM |
In vivo | RF9 (10 μg) infused alone does not result in a significant alteration of MAP or heart rate. When NPFF is applied in conjunction with RF9, MAP, and heart rate increases evoked by NPFF are significantly blocked. It is worthy to note that RF9 (30 nmol) significantly reduces the hypothermia induced by morphine (5 nmol) [1][2]. |
Molecular Weight | 482.62 |
Formula | C26H38N6O3 |
Cas No. | 876310-60-0 |
Relative Density. | 1.42 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 150 mg/mL (310.80 mM), Sonication and heating are recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.